Medicare Enrolled
Dr. Marvi Bikak, M.D
Pulmonary Disease · Palos Heights, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bikak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bikak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bikak
Dr. Marvi Bikak is a pulmonary disease specialist in Palos Heights, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Bikak performed 1,597 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bikak received a total of $22,370 from 32 pharmaceutical and/or device companies across 381 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bikak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 27% volume in IL
$22,370 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,597
Medicare services
Top 27% in IL for pulmonary disease
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $90 | $283 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
207 | $79 | $304 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
171 | $117 | $430 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
162 | $59 | $192 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
142 | $7 | $35 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
139 | $9 | $33 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
137 | $6 | $25 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
110 | $100 | $422 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
99 | $93 | $363 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
62 | $37 | $104 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
33 | $17 | $76 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $89 | $278 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
17 | $30 | $107 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
15 | $87 | $367 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
14 | $283 | $464 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $29 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$22,370
Total received (2018-2024)
Avg $3,728/year across 6 years
Top 10% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
381
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,460
2023
$999
2022
$2,031
2021
$1,626
2020
$216
2018
$38
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$10,970
INTUITIVE SURGICAL, INC.
$5,052
JAZZ PHARMACEUTICALS INC.
$274
GlaxoSmithKline, LLC.
$181
HARMONY BIOSCIENCES LLC
$178
Mylan Specialty L.P.
$164
Baxter Healthcare
$84
Avadel CNS Pharmaceuticals, LLC
$79
Novartis Pharmaceuticals Corporation
$77
Amgen Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Inspire Medical Systems, Inc.
$52
Electromed, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$42
Janssen Biotech, Inc.
$37
Itamar Medical Inc
$28
Harmony Biosciences Llc
$20
GENZYME CORPORATION
$18
Regeneron Healthcare Solutions, Inc.
$18
Grifols USA, LLC
$14
Top 3 companies account for 93.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$12,197
INTUITIVE SURGICAL, INC.
$5,052
GlaxoSmithKline, LLC.
$1,188
Mylan Specialty L.P.
$375
JAZZ PHARMACEUTICALS INC.
$360
Electromed, Inc.
$312
Novartis Pharmaceuticals Corporation
$311
Boehringer Ingelheim Pharmaceuticals, Inc.
$297
Baxter Healthcare
$253
Inspire Medical Systems, Inc.
$239
Amgen Inc.
$237
Janssen Pharmaceuticals, Inc
$205
HARMONY BIOSCIENCES LLC
$178
Grifols USA, LLC
$157
GENZYME CORPORATION
$152
SANOFI-AVENTIS U.S. LLC
$123
Regeneron Healthcare Solutions, Inc.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$90
Avadel CNS Pharmaceuticals, LLC
$79
Genentech USA, Inc.
$51
Sunovion Pharmaceuticals Inc.
$51
Advanced Respiratory, Inc
$51
Itamar Medical Inc
$49
Mallinckrodt Hospital Products Inc.
$46
Inari Medical, Inc.
$45
Janssen Biotech, Inc.
$37
Philips Electronics North America Corporation
$28
MAYNE PHARMA INC.
$27
AbbVie Inc.
$24
Teva Pharmaceuticals USA, Inc.
$21
Harmony Biosciences Llc
$20
NOVARTIS PHARMACEUTICALS CORPORATION
$19
Top 3 companies account for 82.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO ELLIPTA · AirDuo Digihaler · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · Da Vinci Surgical System · ENTYVIO · Esbriet · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · Prolastin-C Liquid · S · SMARTVEST · STELARA · STIOLTO RESPIMAT · SUNOSI · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · WAKIX · WatchPATONE · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
242
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
PALOS COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bikak is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bikak experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bikak performed 252 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bikak receive payments from pharmaceutical companies?
Yes. Dr. Bikak received a total of $22,370 from 32 companies across 381 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bikak's costs compare to other pulmonary diseases in Palos Heights?
Dr. Bikak's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bikak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Palos Heights
Browse pulmonary diseases in Palos Heights ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology